PIIIW (P3 Health Partners Inc. Warrant)
Insider Trading Activity
Every open-market purchase and sale reported by PIIIW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Hudson Vegas Investment Manager, LLC | 10%+ Owner | MIXED | — | — |
| 2026-05-18 | Leif Elliott Pedersen | Chief Financial Officer | A | — | — |
| 2026-01-23 | Thomas Edmunds Price | Director | A | — | — |
| 2026-01-23 | MARY A TOLAN | Director | A | — | — |
| 2026-01-23 | Jeffrey G Park | Director | A | — | — |
| 2026-01-23 | GREGORY D WASSON | Director | A | — | — |
| 2026-01-23 | Gregory N. Kazarian | Director | A | — | — |
| 2026-01-23 | Mark Thierer | Director | A | — | — |
| 2026-01-23 | Lawrence B. Leisure | Director | A | — | — |
| 2025-08-08 | Gregory N. Kazarian | Director | A | — | — |
| 2025-08-08 | MARY A TOLAN | Director | A | — | — |
| 2025-08-08 | Thomas Edmunds Price | Director | A | — | — |
| 2025-08-08 | Lawrence B. Leisure | Director | A | — | — |
| 2025-08-08 | Jeffrey G Park | Director | A | — | — |
| 2025-08-08 | GREGORY D WASSON | Director | A | — | — |
| 2025-08-08 | Mark Thierer | Director | A | — | — |
| 2025-06-06 | Chicago Pacific Founders UGP III, LLC | 10%+ Owner | Buy | — | — |
| 2025-01-31 | Chicago Pacific Founders GP III, L.P. | 10%+ Owner | Buy | — | — |
| 2024-09-13 | CPF III PT SPV, LLC | 10%+ Owner | Buy | — | — |
| 2024-09-12 | Chicago Pacific Founders GP III, L.P. | 10%+ Owner | Buy | — | — |
| 2024-09-11 | CPF III PT SPV, LLC | 10%+ Owner | Buy | — | — |
| 2024-09-10 | CPF III-A PT SPV, LLC | 10%+ Owner | — | — | — |
| 2024-09-10 | CPF III-A PT SPV, LLC | 10%+ Owner | — | — | — |
| 2024-09-10 | Chicago Pacific Founders GP III, L.P. | 10%+ Owner | — | — | — |
| 2024-09-10 | CPF III PT SPV, LLC | 10%+ Owner | Buy | — | — |
| 2024-06-26 | Leavitt Equity Partners II, L.P. | 10%+ Owner | Buy | — | — |
| 2024-06-10 | Gregory N. Kazarian | Director | A | — | — |
| 2024-06-10 | Thomas Edmunds Price | Director | A | — | — |
| 2024-06-10 | GREGORY D WASSON | Director | A | — | — |
| 2024-06-10 | MARY A TOLAN | Director | A | — | — |
| 2024-06-10 | Jeffrey G Park | Director | A | — | — |
| 2024-06-10 | Lawrence B. Leisure | Director | A | — | — |
| 2024-06-10 | Mark Thierer | Director | A | — | — |
| 2024-05-13 | Aric Coffman | See remarks. | A | — | — |
| 2024-01-25 | MARY A TOLAN | Director | A | — | — |
| 2024-01-25 | Thomas Edmunds Price | Director | A | — | — |
| 2024-01-25 | Lawrence B. Leisure | Director | A | — | — |
| 2024-01-25 | GREGORY D WASSON | Director | A | — | — |
| 2024-01-25 | Mark Thierer | Director | A | — | — |
| 2024-01-25 | Jeffrey G Park | Director | A | — | — |
| 2024-01-25 | Gregory N. Kazarian | Director | A | — | — |
| 2024-01-17 | Amir Bacchus | Chief Medical Officer | J | — | — |
| 2024-01-17 | Sherif Abdou | Chief Executive Officer | J | — | — |
| 2024-01-03 | Sherif Abdou | Chief Executive Officer | F | — | — |
| 2024-01-03 | Amir Bacchus | Chief Medical Officer | F | — | — |
| 2023-10-04 | CPF III PT SPV, LLC | 10%+ Owner | Buy | — | — |
| 2023-10-04 | CPF III-A PT SPV, LLC | 10%+ Owner | Buy | — | — |
| 2023-10-04 | CPF III PT SPV, LLC | 10%+ Owner | — | — | — |
| 2023-10-04 | CPF III-A PT SPV, LLC | 10%+ Owner | Buy | — | — |
| 2023-10-04 | CPF III-A PT SPV, LLC | 10%+ Owner | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 104,740,954 | — |
| — | 10%+ Owner | 77,185,438 | — |
| — | 10%+ Owner | 77,025,438 | — |
| — | 10%+ Owner | 49,935,442 | — |
| — | 10%+ Owner | 49,844,708 | — |
| — | 10%+ Owner | 16,919,024 | — |
| — | 10%+ Owner | 8,944,543 | — |
| — | 10%+ Owner | 7,545,264 | — |
| — | Chief Executive Officer | 3,016,662 | — |
| — | Chief Medical Officer | 2,256,491 | — |
| — | Chief Financial Officer | 768,868 | — |
| — | Director | 477,395 | — |
| — | Chief Financial Officer | 450,517 | — |
| — | 10%+ Owner | 50,000 | — |
| — | Director | 23,523 | — |
| — | Director | 21,182 | — |
| — | Director | 6,331 | — |
| — | Director | 6,331 | — |
| — | Director | 6,331 | — |
| — | Director | 6,331 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PIIIW quote page; the site-wide leaderboard is on the insider transactions hub.